# Canadian Imperial Bank of Commerce: financial statements, quarterly

CM · NYSE · CIK 1045520 · [Financials](/sectors/financials.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/cm.md) · [Financials](/companies/cm/financials.md) · [Filings](/companies/cm/filings.md) · [Insiders](/companies/cm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cm/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-10-31) | period not labelled (2016-10-31) | period not labelled (2017-10-31) | FY2018 (2018-10-31) | FY2019 (2019-10-31) | FY2020 (2020-10-31) | FY2021 (2021-10-31) | FY2022 (2022-10-31) | FY2023 (2023-10-31) | FY2024 (2024-10-31) | FY2025 (2025-10-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [3.1](/filings/0001193125-18-337149.md) | [3.5](/filings/0001193125-19-306757.md) | [3.4](/filings/0001193125-20-308976.md) | [4.4](/filings/0001193125-21-346025.md) | [3.8](/filings/0001193125-21-346025.md) | [43.5](/filings/0001193125-22-295936.md) | [34.6](/filings/0001193125-23-285697.md) | [31.5](/filings/0001193125-24-271105.md) | [20.8](/filings/0001193125-25-307488.md) | [8.6](/filings/0001193125-25-307488.md) | [12.4](/filings/0001193125-25-307488.md) |
| Total assets | $bn | not reported | not reported | [565](/filings/0001193125-18-337149.md) | [597](/filings/0001193125-19-306757.md) | [652](/filings/0001193125-20-308976.md) | [770](/filings/0001193125-21-346025.md) | [838](/filings/0001193125-22-295936.md) | [944](/filings/0001193125-23-285697.md) | [976](/filings/0001193125-24-271105.md) | [1,042](/filings/0001193125-25-307488.md) | [1,117](/filings/0001193125-25-307488.md) |
| Total liabilities | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [983](/filings/0001193125-25-307488.md) | [1,053](/filings/0001193125-25-307488.md) |
| Shareholders' equity | $bn | not reported | [23.7](/filings/0001193125-18-337149.md) | [31.0](/filings/0001193125-18-337149.md) | [34.9](/filings/0001193125-19-306757.md) | [38.4](/filings/0001193125-20-308976.md) | [41.2](/filings/0001193125-21-346025.md) | [45.6](/filings/0001193125-22-295936.md) | [50.2](/filings/0001193125-23-285697.md) | [52.9](/filings/0001193125-24-271105.md) | [58.7](/filings/0001193125-25-307488.md) | [64.1](/filings/0001193125-25-307488.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 926,610,598 at 2025-10-31, from the cover of the [40-F filed 2025-12-04](/filings/0001193125-25-307488.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.